Metabolomics Uncovers Biomarkers for PCOS Diagnosis and Therapy – JMSACL
JMSACL (Journal of Mass Spectrometry and Advances in the Clinical Lab) shared a post on LinkedIn:
“Source: (Journal of ovarian research)
Study on PCOS via mass spectrometry metabolomics identified 49 serum metabolites, with 39 upregulated and 10 downregulated. Key findings include altered lipid and amino acid metabolism, revealing candidate biomarkers for diagnosis and therapy. Metabolic pathways affected include sphingolipid metabolism.”
Title: Mass spectrometry-based untargeted metabolomics study of polycystic ovary syndrome
Authors: Ömer Faruk Özer, Ayşe Zeynep İbrahimoğlu, Ayşe Zehra Gül, Metin Demirel, Seda Ateş, Havva Sevde Taha, Merve İbrahimoğlu, Şahabettin Selek
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Aug 3, 2026, 14:19Asmaa Khaled: The Success of IVF is Not Determined By the Number of Eggs Retrieved Alone…
-
Aug 3, 2026, 14:03Clare Mansfield: Sometimes the Path to Parenthood Changes, but the Dream Doesn’t Have To
-
Aug 3, 2026, 13:45Undiga Emuekpere: Basic Fertility Health Awareness Could Change Outcomes
-
Aug 3, 2026, 13:31Priyadatt Patel: A Quiet Inefficiency in How We Approach Infertility Deserves More Attention
-
Aug 3, 2026, 13:21Purabi Gunjal: Most Women Start Thinking about Fertility Too Late…
-
Aug 3, 2026, 13:10Juhee Jain: Empowering Women with the Right Information to Make Informed Decisions
-
Aug 3, 2026, 12:57Ashley Evans: Sometimes, the Thing that Got Me Through Fertility Treatment Wasn’t Positivity…
-
Aug 3, 2026, 12:42Devyanshi Dixit: Why Do the Best Healthcare Professionals Never Stop Learning?
-
Aug 3, 2026, 12:30Bringing Together the Brightest Minds in Reproductive Medicine for 3 Days at MEFS 2026